Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Gether

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Molecular Pharmacology|March 1, 1994
Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptorU Gether, X Emonds-Alt, J C Brelière, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993
A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrationsJ Dal Porto, T E Johansen, B Catipović, et al.
Psychopharmacology|January 11, 2017
Theory of Visual Attention (TVA) applied to mice in the 5-choice serial reaction time taskC M Fitzpatrick, M Caballero-Puntiverio, U Gether, et al.
Molecular Psychiatry|August 28, 2013
De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorderP J Hamilton, N G Campbell, S Sharma, et al.
Molecular Psychiatry|November 21, 2013
Drosophila melanogaster: a novel animal model for the behavioral characterization of autism-associated mutations in the dopamine transporter geneP J Hamilton, N G Campbell, S Sharma, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Molecular Pharmacology|March 1, 1994
Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptorU Gether, X Emonds-Alt, J C Brelière, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993
A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrationsJ Dal Porto, T E Johansen, B Catipović, et al.
Psychopharmacology|January 11, 2017
Theory of Visual Attention (TVA) applied to mice in the 5-choice serial reaction time taskC M Fitzpatrick, M Caballero-Puntiverio, U Gether, et al.
Molecular Psychiatry|August 28, 2013
De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorderP J Hamilton, N G Campbell, S Sharma, et al.
Molecular Psychiatry|November 21, 2013
Drosophila melanogaster: a novel animal model for the behavioral characterization of autism-associated mutations in the dopamine transporter geneP J Hamilton, N G Campbell, S Sharma, et al.
Pageof 6